• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Cardiology

Troponin use for suspected coronary syndrome limited in chronic kidney disease

byKenan Celtik, MSandAimme Li, MD
August 12, 2014
in Cardiology, Chronic Disease, Emergency, Nephrology
Reading Time: 3 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. This systematic review of the literature demonstrated weak or inconclusive evidence regarding the diagnostic accuracy of troponin I (TnI) and troponin I (TnT) in detecting acute coronary syndromes (ACS) for patients with chronic kidney disease (CKD) .

2.  Elevated troponins in patients with CKD may be associated with worse prognosis.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Serum troponin is a specific marker of myocardial damage, and is important in the diagnosis of ACS. In patients with CKD, troponin levels are often persistently elevated, which can make diagnosing ACS challenging in these patients.  This systematic review described 23 peer-reviewed studies on the use of TnI and TnT in suspected ACS in patients with CKD. In this review, 14 studies reported operating characteristics (sensitivity, specificity, positive predictive value, negative predictive value) of troponins in the final diagnosis of an ACS in patients with CKD and the results were variable. Regarding the prognostic value of these assays, TnI or TnT elevation was associated with increased short-term mortality based, although this findings was based on weak evidence. Evidence was insufficient regarding the long-term prognostic value of either TnI or TnT. This study was limited by lack of blinding and moderate to high risk of bias in some studies as well as heterogeneity in the methods for ACS diagnosis and defining CKD. Moreover, there is no standardized cut off level for these assays making comparison across studies challenging. Overall, this systematic review demonstrated that elevated troponins may be useful in the diagnosis and prognosis of ACS in patients with CKD, but standardization of the assays is needed for further study.

Click to read the study, published today in the Annals of Internal Medicine

Relevant Reading: Interpreting cardiac troponin results from highly sensitive assays in patients with chronic kidney disease: acute coronary syndromes and beyond

RELATED REPORTS

Inhaled corticosteroids do not improve outcomes in sickle cell disease patients without asthma

Interim global phase 2 AZUR-1 results show durable responses with dostarlimab monotherapy in untreated MSI-H/dMMR stage II/III locally advanced rectal cancer

In-Depth [systematic review]: This systematic review of available peer-reviewed literature identified 23 studies on the use of elevated TnI and TnT in suspected ACS in patients with CKD. Six studies reported the sensitivity and specificity of troponin T ranging from 71-100% and 31-86%, respectively. Eight studies reported the sensitivity and specificity of troponin I ranging from 43-94% and 48-100%, respectively. Three studies used greater than 1 cut off level for these assays indicating a need for standardization to allow for comparison. None of the studies addressed the potential harms of false positives or the harms/benefits of treating patients based on diagnoses made with these assays. Twelve studies looked at the short and long term prognostic value of troponins, though different methods limited comparison. Low strength evidence showed that elevated TnI and TnT were associated with increased short term mortality, but insufficient evidence limited the determination of long-term outcomes for these assays.

More from this author: Rituximab not beneficial long-term in Sjorgen’s SyndromeHigh-energy shockwave therapy effective in treating shoulder calcific tendinitisTenofovir prophylaxis linked with reduced risk of herpes simplex 2 

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Previous Post

Short course rifamycin matches isoniazid for treatment of tuberculosis

Next Post

Flexible sigmoidoscopy decreases colorectal cancer incidence and mortality

RelatedReports

Sickle cell anemia collage: round and sickle-shaped red blood cells, a wool scarf and a hot-water bottle
All Specialties

Inhaled corticosteroids do not improve outcomes in sickle cell disease patients without asthma

November 20, 2026
Immunotherapy collage: an immune T cell meeting a cancer cell, Y-shaped antibodies and a small key on teal paper
Gastroenterology

Interim global phase 2 AZUR-1 results show durable responses with dostarlimab monotherapy in untreated MSI-H/dMMR stage II/III locally advanced rectal cancer

November 20, 2026
Depression care collage: a calm woman in a linen shirt beside an empty speech bubble, a steaming teacup and a paper sunrise
Artificial Intelligence

AI health chatbot shows no benefit for perinatal anxiety or depression

November 20, 2026
Soft tissue sarcoma collage: arm muscles with an oval outlined in dotted teal, brass calipers and a folded surgical cap
2MM Trial Briefs

ADCE-D01 showed a 30% objective response rate in topline phase 1 results for previously treated advanced soft tissue sarcoma

November 20, 2026
Next Post
Flexible sigmoidoscopy decreases colorectal cancer incidence and mortality

Flexible sigmoidoscopy decreases colorectal cancer incidence and mortality

Radiofrequency catheter ablation effective as first-line therapy for atrial fibrillation [RAAFT-2 trial]

Perioperative atrial fibrillation linked to increased long-term risk of stroke

Tranexamic acid during joint surgery may reduce need for blood transfusions

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Inhaled corticosteroids do not improve outcomes in sickle cell disease patients without asthma
  • Interim global phase 2 AZUR-1 results show durable responses with dostarlimab monotherapy in untreated MSI-H/dMMR stage II/III locally advanced rectal cancer
  • AI health chatbot shows no benefit for perinatal anxiety or depression
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.